Amirian Niloofar, Ranjbaran Reza, Shokrgozar Negin, Ataei Saeed, Bazrafshan Asghar, Sharifzadeh Sedigheh
Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Cytokine. 2021 Apr;140:155425. doi: 10.1016/j.cyto.2021.155425. Epub 2021 Jan 26.
Red blood cell alloimmunization is a challenging issue in thalassemia patients. Several studies have investigated the role of different immune system compartment in alloimmunization, but the exact mechanism remains unclear. Considering the immunoregulatory function of iNKT cells and their subsets, in this study, we evaluated the possible role of these cells in alloimmunization status of thalassemia patients.
78 β-thalassemia major patients (41 alloimmunized and 37 non-alloimmunized) and 17 healthy controls were engaged in this study. Mononuclear cells were isolated from peripheral blood samples and stimulated for cytokine production. Samples were subjected to flow cytometry for enumeration of iNKT cells and characterized based on their cytokine production pattern. Finally, the results correlated with alloimmunization status, clinical and laboratory data.
Results demonstrated that the number of iNKT, iNKTIFN-ɤ+, and iNKTIL-4 cells in thalassemia group was significantly higher than healthy controls while no significant change was observed in the number of these cells between alloimmunized and non-alloimmunized thalassemia patients. Interestingly, the ratio of iNKTIL-4: iNKTIFN-γ cells in alloimmunized thalassemia group represent a considerable increase in comparison to both non-alloimmunized thalassemia group and healthy controls. However, evaluating this value in non-alloimmunized group represents an approximately equal ratio of 0.94, which was almost similar to this ratio in the control group (0.99).
Our results illustrated a noteworthy imbalance in the ratio of iNKT cell subsets in favour of IL-4 producing iNKT cells in alloimmunized thalassemia patients. Regarding the role of IL-4 in stimulating the Th2-related immune responses, this imbalance could consider as a possible mechanism in alloantibody responses of thalassemia patients.
红细胞同种免疫是地中海贫血患者面临的一个具有挑战性的问题。多项研究探讨了不同免疫系统组成部分在同种免疫中的作用,但确切机制仍不清楚。考虑到不变自然杀伤T(iNKT)细胞及其亚群的免疫调节功能,在本研究中,我们评估了这些细胞在地中海贫血患者同种免疫状态中的可能作用。
本研究纳入了78例重型β地中海贫血患者(41例发生同种免疫,37例未发生同种免疫)和17名健康对照者。从外周血样本中分离单核细胞并刺激其产生细胞因子。对样本进行流式细胞术以计数iNKT细胞,并根据其细胞因子产生模式进行表征。最后,将结果与同种免疫状态、临床和实验室数据相关联。
结果表明,地中海贫血组中iNKT细胞、iNKTIFN-ɤ+细胞和iNKTIL-4细胞的数量显著高于健康对照者,而在发生同种免疫和未发生同种免疫的地中海贫血患者之间,这些细胞的数量未观察到显著变化。有趣的是,与未发生同种免疫的地中海贫血组和健康对照者相比,发生同种免疫的地中海贫血组中iNKTIL-4:iNKTIFN-γ细胞的比例有相当大的增加。然而,在未发生同种免疫的组中评估该值时,其比例约为0.94,与对照组的该比例(0.99)几乎相似。
我们的结果表明,在发生同种免疫的地中海贫血患者中,iNKT细胞亚群的比例存在显著失衡,有利于产生IL-4的iNKT细胞。鉴于IL-4在刺激Th2相关免疫反应中的作用,这种失衡可被视为地中海贫血患者同种抗体反应的一种可能机制。